Silver Book Fact

Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same as those 30 years ago, 815,000 more Americans would die of heart disease annually and 250,000 more would die of stroke.

PhRMA. 2009 Report: Medicines in development for heart disease and stroke. Washington, D.C.: PhRMA; 2009. http://www.phrma.org/sites/default/files/653/heart_2009

Reference

Title
2009 Report: Medicines in development for heart disease and stroke
Publisher
PhRMA
Publication Date
2009
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Spending $1,000 per year on anticoagulants can save $100,000 in hospital costs for care of a person disabled by a stroke.  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • The percentage of Americans age 55-64 with high cholesterol decreased between 1988-94 and 1999-2002, in part because of the increased awareness about the risks of high cholesterol and the increased…  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • While treatment with antihypertensives has already generated a benefit-to-cost ratio of at least 6:1 (6:1 for women and 10:1 for men), more effective use of antihypertensive medication would have an…